Stroke Trial, Recruiting NCT06650436 Sponsor: Universitair Ziekenhuis Brussel Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06650436
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been clinically diagnosed with their first-ever ischemic stroke (a stroke caused by a blocked blood vessel), where symptoms started less than 72 hours before being enrolled in the study
  • People who have been admitted to the stroke unit at UZ Brussel hospital
  • People who are able to participate in memory and thinking assessments
  • People who are fluent in Dutch or French
  • People who are able to have an EEG (a test that measures brain activity) within the first 24 hours after stroke symptoms began
  • People who are able to have an MRI scan of the brain

Who may not be able to join:

  • People who have a history of epilepsy
  • People who have a pre-existing growth or mass in the brain (except for a small meningioma, which is a usually non-cancerous tumour — confirm with trial site)
  • People who are pregnant or who wish to become pregnant
  • People who have severe difficulties with language or dementia that would prevent them from completing the thinking and memory assessments
  • People whose life expectancy is less than one year

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 024776801

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universitair Ziekenhuis Brussel
Registry
ClinicalTrials.gov
Start date
20 May 2024
Est. completion
1 May 2026

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Post-stroke delirium; The role of brain network disintegration in post-stroke delirium: electrical analysis of the relative power in the alfa frequency band; The role of brain network disintegration in post-stroke delirium: electrical analysis of the relative power in the beta frequency band; The role of brain network disintegration in post-stroke delirium: electrical analysis of the relative power in the delta frequency band; The role of brain network disintegration in post-stroke delirium: electrical analysis of the relative power in the theta frequency band; The role of brain network disint...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov